Adam Dubow Day One Biopharmaceuticals, Inc. (DAWN) insider trading activity

DAWN Quotes by TradingView

Adam Dubow is GENERAL COUNSEL of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 39,602 shares of DAWN, which is worth approximately $319,588. The most recent transaction as insider was on Feb 18, 2025, when has been sold 4,646 shares (Common Stock) at a price of $11.96 per share, resulting in proceeds of $55,566. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.6K
23.13% 3M change
138.78% 12M change
Total Value Held $319,588

Adam Dubow Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 18 2025
SELL
Open market or private sale
$55,566 $11.96 p/Share
4,646 Reduced 10.5%
39,602 Common Stock
Feb 15 2025
BUY
Exercise of conversion of derivative security
-
12,086 Added 21.45%
44,248 Common Stock
Nov 18 2024
SELL
Open market or private sale
$41,809 $13.21 p/Share
3,165 Reduced 8.96%
32,162 Common Stock
Nov 15 2024
BUY
Exercise of conversion of derivative security
-
8,399 Added 19.21%
35,327 Common Stock
Aug 16 2024
SELL
Open market or private sale
$44,828 $14.0 p/Share
3,202 Reduced 10.63%
26,928 Common Stock
Aug 15 2024
BUY
Exercise of conversion of derivative security
-
8,399 Added 21.8%
30,130 Common Stock
May 16 2024
SELL
Open market or private sale
$52,308 $16.08 p/Share
3,253 Reduced 13.02%
21,731 Common Stock
May 15 2024
BUY
Exercise of conversion of derivative security
-
8,399 Added 25.16%
24,984 Common Stock
Feb 16 2024
SELL
Open market or private sale
$49,440 $15.25 p/Share
3,242 Reduced 16.35%
16,585 Common Stock
Feb 15 2024
BUY
Exercise of conversion of derivative security
-
8,399 Added 29.76%
19,827 Common Stock
Nov 16 2023
SELL
Open market or private sale
$62,108 $11.69 p/Share
5,313 Reduced 31.74%
11,428 Common Stock
Nov 15 2023
BUY
Exercise of conversion of derivative security
-
13,600 Added 44.82%
16,741 Common Stock

Also insider at

BMY
BRISTOL MYERS SQUIBB CO Healthcare
SVP,ChiefCompliance&EthicsOff.
AD

Adam Dubow

GENERAL COUNSEL
New York, NY

Track Institutional and Insider Activities on DAWN

Follow Day One Biopharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Insider Trading

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

News

Receive news related to Day One Biopharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DAWN